Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CDED + penicillin
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
CDED + penicillin is a combination therapy approach for inflammatory bowel disease (IBD), particularly Crohn's disease, that combines the Crohn's Disease Exclusion Diet (CDED) with penicillin-class antibiotics. This approach aims to manage gut inflammation and dysbiosis through dietary modification while using antibiotics to target specific bacterial populations. Penicillin antibiotics, such as amoxicillin, are often used in combination with other antibiotics for refractory IBD cases.
- Other names
- Crohn's Disease Exclusion Diet with penicillin
02
Targets
Beyond the preview
Go deeper on CDED + penicillin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CDED + penicillin.